368 related articles for article (PubMed ID: 27569663)
1. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.
Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R
J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663
[TBL] [Abstract][Full Text] [Related]
2. Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex.
Ofek P; Calderón M; Mehrabadi FS; Krivitsky A; Ferber S; Tiram G; Yerushalmi N; Kredo-Russo S; Grossman R; Ram Z; Haag R; Satchi-Fainaro R
Nanomedicine; 2016 Oct; 12(7):2201-2214. PubMed ID: 27262933
[TBL] [Abstract][Full Text] [Related]
3. Modulation of MicroRNAs 34a and 21 Affects Viability, Senescence, and Invasion in Glioblastoma Multiforme.
Yin Y; Ornell KJ; Beliveau A; Jain A
J Biomed Nanotechnol; 2016 Sep; 12(9):1782-97. PubMed ID: 29345889
[TBL] [Abstract][Full Text] [Related]
4. Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma.
Khan MB; Ruggieri R; Jamil E; Tran NL; Gonzalez C; Mugridge N; Gao S; MacDiarmid J; Brahmbhatt H; Sarkaria JN; Boockvar J; Symons M
Mol Med; 2021 Mar; 27(1):28. PubMed ID: 33765907
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
6. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment.
Jana A; Narula P; Chugh A; Kulshreshtha R
Int J Pharm; 2019 Dec; 572():118789. PubMed ID: 31726199
[TBL] [Abstract][Full Text] [Related]
7. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
8. Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme.
Wang F; Jiang H; Wang S; Chen B
Cell Mol Neurobiol; 2017 Nov; 37(8):1433-1442. PubMed ID: 28213656
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma.
Wang K; Kievit FM; Jeon M; Silber JR; Ellenbogen RG; Zhang M
Adv Healthc Mater; 2015 Dec; 4(17):2719-26. PubMed ID: 26498165
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme.
Li WB; Ma MW; Dong LJ; Wang F; Chen LX; Li XR
Cancer Biol Ther; 2011 Sep; 12(6):477-83. PubMed ID: 21743299
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44.
Yeh M; Wang YY; Yoo JY; Oh C; Otani Y; Kang JM; Park ES; Kim E; Chung S; Jeon YJ; Calin GA; Kaur B; Zhao Z; Lee TJ
Sci Rep; 2021 Apr; 11(1):9219. PubMed ID: 33911148
[TBL] [Abstract][Full Text] [Related]
12. microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis.
Rezaei T; Hejazi M; Mansoori B; Mohammadi A; Amini M; Mosafer J; Rezaei S; Mokhtarzadeh A; Baradaran B
Eur J Pharmacol; 2020 Dec; 888():173483. PubMed ID: 32810491
[TBL] [Abstract][Full Text] [Related]
13. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.
C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O
Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939
[TBL] [Abstract][Full Text] [Related]
14. MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2.
Sun J; Zheng G; Gu Z; Guo Z
J Neurooncol; 2015 May; 122(3):481-9. PubMed ID: 25939439
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
Zhang S; Lai N; Liao K; Sun J; Lin Y
Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314
[TBL] [Abstract][Full Text] [Related]
16. miR-6858 plays a key role in the process of melatonin inhibition of the malignant biological behavior of glioma.
Wang C; Zhao Z; Qi Q; Wang J; Kong Y; Feng Z; Chen A; Li W; Zhang Q; Wang J; Huang B; Li X
J Clin Neurosci; 2021 May; 87():137-146. PubMed ID: 33863521
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3).
Yang CH; Yue J; Pfeffer SR; Fan M; Paulus E; Hosni-Ahmed A; Sims M; Qayyum S; Davidoff AM; Handorf CR; Pfeffer LM
J Biol Chem; 2014 Sep; 289(36):25079-87. PubMed ID: 25059666
[TBL] [Abstract][Full Text] [Related]
18. Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy.
Liu Y; Zheng M; Jiao M; Yan C; Xu S; Du Q; Morsch M; Yin J; Shi B
Biomaterials; 2021 Sep; 276():121036. PubMed ID: 34329919
[TBL] [Abstract][Full Text] [Related]
19. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
[TBL] [Abstract][Full Text] [Related]
20. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
